- Home
- CRDF vs NREF Comparison
CRDF vs NREF Comparison
Compare CRDF & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- NREF
- Stock Information
- Founded
- CRDF 1999
- NREF 2019
- Country
- CRDF United States
- NREF United States
- Employees
- CRDF N/A
- NREF N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- NREF Real Estate Investment Trusts
- Sector
- CRDF Health Care
- NREF Real Estate
- Exchange
- CRDF Nasdaq
- NREF Nasdaq
- Market Cap
- CRDF 233.5M
- NREF 244.3M
- IPO Year
- CRDF N/A
- NREF 2020
- Fundamental
- Price
- CRDF $2.32
- NREF $15.34
- Analyst Decision
- CRDF Strong Buy
- NREF Hold
- Analyst Count
- CRDF 6
- NREF 4
- Target Price
- CRDF $10.58
- NREF $14.75
- AVG Volume (30 Days)
- CRDF 2.9M
- NREF 37.9K
- Earning Date
- CRDF 07-29-2025
- NREF 07-31-2025
- Dividend Yield
- CRDF N/A
- NREF 13.04%
- EPS Growth
- CRDF N/A
- NREF N/A
- EPS
- CRDF N/A
- NREF 2.59
- Revenue
- CRDF $545,000.00
- NREF $121,573,000.00
- Revenue This Year
- CRDF N/A
- NREF $27.69
- Revenue Next Year
- CRDF N/A
- NREF $5.49
- P/E Ratio
- CRDF N/A
- NREF $5.92
- Revenue Growth
- CRDF N/A
- NREF 302.49
- 52 Week Low
- CRDF $2.09
- NREF $12.14
- 52 Week High
- CRDF $5.64
- NREF $18.09
- Technical
- Relative Strength Index (RSI)
- CRDF 34.12
- NREF 66.17
- Support Level
- CRDF $2.22
- NREF $14.35
- Resistance Level
- CRDF $2.56
- NREF $14.80
- Average True Range (ATR)
- CRDF 0.13
- NREF 0.31
- MACD
- CRDF 0.01
- NREF 0.10
- Stochastic Oscillator
- CRDF 25.64
- NREF 97.46
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.